Exact Mass: 438.0947

Exact Mass Matches: 438.0947

Found 21 metabolites which its exact mass value is equals to given mass value 438.0947, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Riboflavin cyclic-4',5'-phosphate

10-[(2S,3S)-2,3-dihydroxy-3-[(4R)-2-hydroxy-2-oxo-1,3,2λ⁵-dioxaphospholan-4-yl]propyl]-4-hydroxy-7,8-dimethyl-2H,10H-benzo[g]pteridin-2-one

C17H19N4O8P (438.094)


Riboflavin cyclic-4,5-phosphate, also known as cfmn or cyclic flavin mononucleotide, is a member of the class of compounds known as flavins. Flavins are compounds containing a flavin (7,8-dimethyl-benzo[g]pteridine-2,4-dione) moiety, with a structure characterized by an isoalloaxzine tricyclic ring. Riboflavin cyclic-4,5-phosphate is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Riboflavin cyclic-4,5-phosphate can be found in a number of food items such as sea-buckthornberry, horseradish tree, malabar spinach, and wild rice, which makes riboflavin cyclic-4,5-phosphate a potential biomarker for the consumption of these food products. Riboflavin cyclic-4,5-phosphate is part of the Glycerolipid metabolism, and RIG-I-like receptor signaling pathway pathways. It is a substrate for: Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing).

   

5-demethoxycadensin G

5-demethoxycadensin G

C23H18O9 (438.0951)


   

Hypnum acid methyl ester

3,5,7,4-Tetrahydroxyflavanone 3-(4-hydroxybenzoic acid methyl ester)

C23H18O9 (438.0951)


   

(2S,3R)-3,10-dihydroxy-9-O-(6-hydroxy-7-O-methyl-2-hydroxymethyldihydrobenzofuran-3-yl)dibenz--pyran-6-one

(2S,3R)-3,10-dihydroxy-9-O-(6-hydroxy-7-O-methyl-2-hydroxymethyldihydrobenzofuran-3-yl)dibenz--pyran-6-one

C23H18O9 (438.0951)


   

4-hydroxytetracenomycin A2

4-hydroxytetracenomycin A2

C23H18O9 (438.0951)


   

10-[(2R,3R)-2,3-dihydroxy-3-[(4S)-2-hydroxy-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]propyl]-7,8-dimethylbenzo[g]pteridine-2,4-dione

10-[(2R,3R)-2,3-dihydroxy-3-[(4S)-2-hydroxy-2-oxo-1,3,2lambda5-dioxaphospholan-4-yl]propyl]-7,8-dimethylbenzo[g]pteridine-2,4-dione

C17H19N4O8P (438.094)


   

(E)-2-hydroxy-1-[4,5,7,10-tetrahydroxy-3-(3-oxobutanoyl)anthracen-2-yl]pent-2-ene-1,4-dione

(E)-2-hydroxy-1-[4,5,7,10-tetrahydroxy-3-(3-oxobutanoyl)anthracen-2-yl]pent-2-ene-1,4-dione

C23H18O9 (438.0951)


   

Riboflavin cyclic-4,5-phosphate

Riboflavin cyclic-4,5-phosphate

C17H19N4O8P (438.094)


   

riboflavin cyclic 4,5-phosphate

riboflavin cyclic 4,5-phosphate

C17H19N4O8P (438.094)


A flavin mononucleotide that is riboflavin (vitamin B2) in which the 4 and 5 hydroxy groups have been converted into a cyclic hydrogen phosphate ester.

   

VU 6008667

VU 6008667

C24H17ClF2N2O2 (438.0947)


VU 6008667 is a selective negative allosteric modulator of M5 NAM with IC50s of 1.2 μM and 1.6 μM for human M5 and rat M5, respectively. High CNS penetration[1].

   

3,10-dihydroxy-9-{[6-hydroxy-2-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]oxy}benzo[c]chromen-6-one

3,10-dihydroxy-9-{[6-hydroxy-2-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]oxy}benzo[c]chromen-6-one

C23H18O9 (438.0951)


   

methyl 3-(3,4-dihydroxyphenyl)-2-{6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoate

methyl 3-(3,4-dihydroxyphenyl)-2-{6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoate

C23H18O9 (438.0951)


   

methyl 2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carboxylate

methyl 2',6-dihydroxy-5'-(3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl)-[1,1'-biphenyl]-3-carboxylate

C23H18O9 (438.0951)


   

(2r,3s)-7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one

(2r,3s)-7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one

C23H18O9 (438.0951)


   

methyl 2',6-dihydroxy-5'-[(2s,3s)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylate

methyl 2',6-dihydroxy-5'-[(2s,3s)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylate

C23H18O9 (438.0951)


   

7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one

7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one

C23H18O9 (438.0951)


   

methyl 2',6-dihydroxy-5'-[(2s,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylate

methyl 2',6-dihydroxy-5'-[(2s,3r)-3,5,7-trihydroxy-4-oxo-2,3-dihydro-1-benzopyran-2-yl]-[1,1'-biphenyl]-3-carboxylate

C23H18O9 (438.0951)


   

(2r,3r)-7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one

(2r,3r)-7,9-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4,5-trioxatetraphen-10-one

C23H18O9 (438.0951)


   

methyl (2z)-3-(3,4-dihydroxyphenyl)-2-{6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoate

methyl (2z)-3-(3,4-dihydroxyphenyl)-2-{6-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-2-oxopyran-3-yl}prop-2-enoate

C23H18O9 (438.0951)


   

3,10-dihydroxy-9-{[(2s,3r)-6-hydroxy-2-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]oxy}benzo[c]chromen-6-one

3,10-dihydroxy-9-{[(2s,3r)-6-hydroxy-2-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-3-yl]oxy}benzo[c]chromen-6-one

C23H18O9 (438.0951)